ArticleACS pharmacology & translational science2024

Developing MYC Degraders Bearing the Von Hippel-Lindau Ligand to Target the "Undruggable" MYC.

Christos Siokatas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.